A Phase II, Open-label Pilot Study Evaluating the Safety and Activity of Liposomal Irinotecan in Combination With 5-FU and Oxaliplatin in Preoperative Treatment of Pancreatic Adenocarcinoma (NEO-Nal- IRI Study)
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2019
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- Acronyms NEO-Nal- IRI Study
- 19 Jan 2019 Study design was presented at the 2019 Gastrointestinal Cancers Symposium.
- 11 Dec 2018 Planned End Date changed from 1 Sep 2020 to 1 Dec 2021.
- 11 Dec 2018 Planned primary completion date changed from 1 Sep 2020 to 1 Sep 2021.